Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2025-12-24 @ 10:52 PM
NCT ID:
NCT04034069
Eligibility Criteria:
Inclusion Criteria:
* with a diagnosis of a unilateral ischemic or hemorrhagic stroke;
* with stroke onset more than 6 months;
* from 18 to 75 years old;
* with mild to moderate impairment of upper limb functions due to stroke, measured using the Hong Kong Version of the Functional Test for the Hemiplegic Upper Extremity (FTHUE-HK) from level 2 to level 7;
* be able to understand verbal instruction and follow one-step commands;
* be able to give informed consent to participate;
Exclusion Criteria:
* any contraindications to rTMS/TBS, such as unstable medical condition, history of epileptic seizures, metal implants in vivo (eg, pacemaker, artificial cochlear, and implant brain stimulator), and a history of receiving craniotomy;
* previous diagnosis of any neurological disease excluding stroke;
* presence of any sign of cognitive problems (Abbreviated mental test Hong Kong version \< 6/10);
* patients with extreme spasticity in any hemiplegic upper limb joint (Modified Ashworth score \> 2) or severe pain that hinder the upper limb motor training;
* with other notable impairment of the upper limb affected by stroke, eg, recent fracture, severe osteoarthritis, congenital upper limb deformity
* any sign of anxiety or depression, as assessed by the Hospital Anxiety and Depression Scale.
* concurrent participation in an upper limb rehabilitation program or a medicine trial.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04034069
Study Brief:
Protocol Section:
NCT04034069